IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-018-08013-z.html
   My bibliography  Save this article

Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis

Author

Listed:
  • Yuan He

    (University Medical Center Groningen (UMCG))

  • Renee Bouwstra

    (University Medical Center Groningen (UMCG))

  • Valerie R. Wiersma

    (University Medical Center Groningen (UMCG))

  • Mathilde de Jong

    (University Medical Center Groningen (UMCG))

  • Harm Lourens

    (University Medical Center Groningen (UMCG))

  • Rudolf Fehrmann

    (University Medical Center Groningen (UMCG))

  • Marco de Bruyn

    (University Medical Center Groningen (UMCG))

  • Emanuele Ammatuna

    (University Medical Center Groningen (UMCG))

  • Gerwin Huls

    (University Medical Center Groningen (UMCG))

  • Tom van Meerten

    (University Medical Center Groningen (UMCG))

  • Edwin Bremer

    (University Medical Center Groningen (UMCG))

Abstract

CD47 is a prominent new target in cancer immunotherapy, with antagonistic antibodies currently being evaluated in clinical trials. For effective evaluation of this strategy it is crucial to identify which patients are suited for CD47-targeted therapy. In this respect, expression of the pro-phagocytic signal SLAMF7 on both macrophages and cancer cells was recently reported to be a requisite for CD47 antibody-mediated phagocytosis. Here, we demonstrate that in fact SLAMF7 expression on cancer cells is not required and does not impact on CD47 antibody therapy. Moreover, SLAMF7 also does not impact on phagocytosis induction by CD20 antibody rituximab nor associates with overall survival of Diffuse Large B-Cell Lymphoma patients. In contrast, expression of CD47 negatively impacts on overall and progression free survival. In conclusion, cancer cell expression of SLAMF7 is not required for phagocytosis and, in contrast to CD47 expression, should not be used as selection criterion for CD47-targeted therapy.

Suggested Citation

  • Yuan He & Renee Bouwstra & Valerie R. Wiersma & Mathilde de Jong & Harm Lourens & Rudolf Fehrmann & Marco de Bruyn & Emanuele Ammatuna & Gerwin Huls & Tom van Meerten & Edwin Bremer, 2019. "Cancer cell-expressed SLAMF7 is not required for CD47-mediated phagocytosis," Nature Communications, Nature, vol. 10(1), pages 1-8, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08013-z
    DOI: 10.1038/s41467-018-08013-z
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-018-08013-z
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-018-08013-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-08013-z. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.